-
2025-520490-38-00
3
2025-10-13
Haemophilia A with or without inhibitors. Proposed indication under de
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-518759-45-00
5
2025-10-07
Children primary nephropathy IgA
-
2024-518714-31-00
5
2025-10-03
Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2025-520473-40-00
4
2025-09-29
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
-
2024-514186-18-00
1
2025-09-09
Systemic Lupus Erythematosus
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2023-508875-35-00
5
2025-09-01
Heart condition
-
2024-518856-21-00
4
2025-08-28
Mild to severe palmoplantar pustulosis
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2024-516337-12-00
5
2025-08-07
Knee osteoarthritis with moderate to severe pain
-
2024-520328-27-00
4
2025-08-07
Type 2 Diabetes
-
2022-502983-19-00
4
2025-07-31
High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cance
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-519291-11-00
4
2025-07-25
Psoriatic Arthritis
-
2023-503634-50-01
5
2025-07-22
Anemia in patients with chronic kidney disease on dialysis
-
2024-517991-39-00
5
2025-07-22
Asthma
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-516834-36-00
5
2025-07-08
Locally recurrent unresectable or metastatic TNBC with tumors expressi
-
2024-513111-27-00
5
2025-06-26
Psoriatic Arthritis
-
2024-515796-35-00
4
2025-06-26
Heart Failure with Preserved Ejection Fraction and Left Ventricular Hy